Ultimate Fighting Championship lightweight Thibault Gouti has accepted a six-month suspension for failing an out-of-competition drug test on March 12.
According to USADA, Gouti tested positive after taking a supplement that contained multiple banned substances, including ostarine, a selective androgen receptor module that can assist athletes in training by improving stamina. Gouti received a reduced sanction because he returned the supplement shortly after its purchase and notified USADA of its contents and use.
As a result, USADA has added the product to its list of high-risk supplements. Gouti’s suspension, meanwhile, is retroactive to April 25, meaning that he will be eligible to return to active competition on Oct.